From January 1, 2024 to March 22, 2024, the company has repurchased 0 shares, representing 0% for ¥0 million. With this, the company has completed the repurchase of 12,571,400 shares, representing 3.38% for ¥16,178.35 million under the buyback announced on May 11, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,644 JPY | +0.95% | +3.33% | +16.98% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.98% | 3.76B | |
+40.73% | 739B | |
+31.56% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.53% | 240B | |
+9.58% | 210B | |
-5.32% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- 4536 Stock
- News Santen Pharmaceutical Co., Ltd.
- Tranche Update on Santen Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2023.